Lactizip Syrup contains Lactitol, a synthetic disaccharide used primarily as an osmotic laxative for the treatment of chronic constipation and to facilitate bowel evacuation before diagnostic procedures. Lactitol acts by drawing water into the colon, thereby softening stools and increasing bowel motility without causing significant electrolyte imbalance. It is minimally absorbed in the gastrointestinal tract, making it effective and well-tolerated for long-term use. Lactizip Syrup is indicated for patients experiencing constipation due to various causes, including opioid-induced constipation, and is also utilized in managing hepatic encephalopathy by reducing ammonia absorption through its laxative effect. The syrup formulation allows for easy administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on patient response, with typical adult doses ranging from 10 to 40 grams per day, divided into one or two doses. Common side effects may include flatulence, abdominal discomfort, and diarrhea if overdosed. Lactizip Syrup should be used cautiously in patients with galactosemia or intestinal obstruction. It is contraindicated in cases of hypersensitivity to Lactitol or other components. Regular monitoring and adherence to prescribed dosing are essential to ensure therapeutic efficacy and minimize adverse effects.